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Abstract
OBJECTIVE: To investigate the effectiveness of
Shoushen granule, Chinese herbal preparation, on
carotid artery elasticity in patients with carotid ath-
erosclerosis.
METHODS: The total of 156 carotid atherosclerosis
patients were randomly divided into the interven-
tion group (83 cases, treated with Shoushen gran-
ule) and the control group (73 cases, treated with
pravastatin). Brachial-ankle pulse wave velocity
(baPWV) and Ankle-Brachial Pressure Index (ABI)
were measured by automated arteriosclerosis de-
tector. The changes of common carotid artery inti-
ma-media thickness (IMT) and parameters of the
carotid artery elasticity in patients, including stiff-
ness parameter (β), pressure-strain elastic modulus
(Ep), arterial compliance (Ac), augmentation index
(AI), and pulse wave velocity β (PWVβ) were detect-
ed by Echo-Tracking (ET) technique before and af-
ter 24 week treatment. In the meantime, levels of
blood lipid, and liver and renal function were mea-
sured respectively.
RESULTS: After 24 weeks, baPWV, IMT and parame-
ters of the carotid artery elasticity (β, Ep, AI and
PWVβ) were markedly decreased in intervention
group compared with those of before treatment
(P < 0.01), but the level of Ac was increased signifi-
cantly (P < 0.01). And there were no significant dif-
ferences compared with control group on the same
period (P > 0.05).
CONCLUSION: In this pilot study, it was demon-
strated ET technology and automated arteriosclero-
sis detector could be used to evaluate carotid ar-
tery elasticity effectively, and the action of Shoush-
en granule on carotid atherosclerosis might be re-
lated to the regulation of carotid artery elasticity.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Atherosclerosis is a condition characterized by vessel
wall thickening that occurs over decades. Ultimately
the process becomes clinically manifest as acute cardio-
vascular events in many individuals. Atherosclerosis un-
derlies the vast majority of cardiovascular disease and
cause death and disability. Arterial stiffness is a func-
tional change of arteries, as opposed to arterial wall
thickening, which is a morphological change.1 Arterial
stiffness is one aspect of atherosclerosis, and affects the
morbidity and mortality associated with cardiovascular
diseases.2 Increased arterial stiffness is an independent
risk marker of premature coronary artery disease, ath-
erosclerosis, and cardiovascular mortality.3 The measure
of common carotid artery intima-media thickness
(IMT) has been extensively used as an early marker of
atherosclerosis in epidemiologic and clinical studies.4
Longitudinal studies showed that increased IMT pre-
dicts carotid plaque occurrence5 and stroke.6 However,
IMT only provides information about vessel anatomy,
other important aspects of atherosclerosis related to ves-
sel function, such as wall composition of stiffness, can
also be studied in atherosclerosis with other noninva-
sive technique. In addition, carotid artery dilatation in-
dicates compensatory vascular mechanism and is found
in early stages of atherosclerosis.7 PWV is a rather ma-
ture and classic method for measuring arterial stiffness.
Measuring arterial PWV, which reflects the elasticity of
the arterial wall between two points, is highly accurate
and repeatable. Ultrasound Echo-Tracking (ET) tech-
nology has also become widely used for evaluating ca-
rotid stiffness in scientific research. Echo tracking sys-
tems, especially high resolution ones, may provide easy
to measure local arterial stiffness parameters in the de-
tection of early functional arterial changes that precede
vascular structural remodeling. Echo tracking also pro-
vide reliable measurements of lumen size, distensibility,
wall thickness, and the presence of atheroma in large ar-
teries.8
Traditional Chinese Medicinal (TCM) usually is used
to restore the balance of Yin-Yang of body energy so
that the body's normal function and homeostasis is
maintained. TCM has been widely used in the clinical
practice for preventing atherosclerosis with less side-ef-
fect.9 Method of reinforcing kidney, in terms of TCM
theory, is therapeutical principle for the treatment of
atherosclerosis.10 Previous research indicated that
Shoushen granule was effective for preventing athero-
sclerosis.11,12 In this study, we aimed to investigate the
possible mechanism underpinned the anti-atherosclero-
sis action of Shoushen granule.
MATERIALS ANDMETHODS
Subjects
All the participants were recruited from those attend-
ing the Shanghai Municipal Hospital of TCM, Depart-
ment of Gerontology specialist out-patient clinics of
atherosclerosis, from June 2011 to June 2012. The
study was approved by The Ethics Committee of
Shanghai Municipal Hospital of Traditional Chinese
Medicine and was performed in accordance with the
principles outlined in the Declaration of Helsinki. The
informed consent was obtained from all patients.
Inclusion and exclusion criteria
The diagnosis of carotid atherosclerosis was based on
clinical history and the guidelines.13 To be included
in the study, all patients had to have IMT ≥ 0.9 mm
and brachial-ankle pulse wave velocity (baPWV) >
1400 mm/s. Other inclusion criteria included an age
of 45 to 65 years old. Patients were excluded if they
had any of the following: (a) who did not fit the above
diagnosis; (b) not signed the informed consent ; (c)
with acute injury of liver and renal functions; (d) with
acute myocardial infarction, major surgery to cerebral
vessels, or severe accidental damage in the previous 12
months; (e) with peripheral arterial disease (PAD); (f )
who were on medication for lipid management; (g) at
pregnancy and lactation; (h) serious blood disease; (i)
psychiatric disorder.
Study design and intervention
The study was designed as an open, single-center ran-
domized controlled trial including two parallel groups.
After the eligible screening visit, participants entered a
2-week run-in phase: blood samples were obtained at
baseline by our research nurse and checked by Shang-
hai Municipal Hospital of Traditional Chinese Medi-
cine. Baseline data including blood lipid, liver and re-
nal function tests, fasting blood sugar and creatine
phosphokinase, were collected. After the run-in phase,
block randomization method was applied, and patients
were randomly divided by a random table into inter-
vention group and control group with Version 9.0
(SAS Institute Inc., Cary, NC, USA). Groups were allo-
cated randomly according to outpatient serial number
paired with random number table. Intervention group,
31 males and 52 females, was treated with Shoushen
granule, a recipe of TCM for reinforcing kidney in
terms of TCM's theory. Patients were instructed to dis-
solve a sachet of granule (6.2 g) in 200 mL of hot wa-
ter, they took this solution orally twice daily for 24
weeks. Control group, 25 males and 48 females, was
treated with Pravastatin (a drug for lipid regulation
and anti-atherosclerosis), for which each tablet consist-
ed 10 mg Pravastatin Sodium. Patients were instructed
to take 1 tablet once daily for 24 weeks. The baseline
characteristics of the two groups of patients are shown
in Table 2. In this pilot study, all patients were not
treated by any other complementary and/or alternative
treatment such as other traditional Chinese medicine
including acupuncture, and excluded were those who
had taken medicines for lipid management.
Drugs and Shoushen granule
Pravastatin Sodium was manufactured by Sino Ameri-
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can Shanghai Squib Pharmaceutical Co., Ltd., batch
number: H10950315. Shoushen granule, a preparation
for reinforcing kidney in terms of TCM's theory, was
manufactured by Jiangyin Tianjiang Pharmaceutical
Co., Ltd., Jiangyin, China, batch number: 1012350.
The preparation was made from Chinese herbs consist-
ing of: Heshouwu (Radix Polygoni Multiflori), Gouqizi
(Fructus Lycii), Shanzha (Fructus Crataegus Pinnatifi-
dae) and Sanqi (Radix Notoginseng).
Measurement
baPWV and ABI were measured using automated arte-
riosclerosis detector, BP203RPE-Ⅱ, VP-1000 (Colin
Co., Kyoto, Japan). Subjects lie on their back after tak-
ing 5 min of rest, and then had their both upper arms
and ankles wrapped around by cuffs containing sensors
which record pulse wave generated from brachial arter-
ies and tibial arteries. The waveform between brachial
artery to tibial arteries and data were obtained from the
device. After a 5 min rest in a supine position, parame-
ters including baPWV, ABI, blood pressure in the four
limbs, electrocardiogram, and heart sounds were re-
corded simultaneously.
A ProSound α10 sonographic system (Aloka Co., Ltd.,
Tokyo, Japan) with ET technology, a built-in digital
image management system (e-DMS), and a 7-15 MHz
linear transducer, were used to assess the physical prop-
erties of the common carotid artery. All patients were
instructed not to smoke or drink alcohol or coffee one
hour prior to the measurements and asked to rest for
not less than 15 min. The device made use of a highly
focalized transducer that was positioned over the bilat-
eral carotid artery 2 to 4 cm above the collar, direct
contact with the skin being prevented by the use of a
gel medium. IMT was measured on both common ca-
rotid arteries 1, 2, 3 cm respectively from the proxi-
mate distally wall of carotid crotch, and ET was per-
formed at the same site. ET technology was used for
tracking and tracing the movements of the superficial
and deep walls of the carotid artery on the ultrasound
radiofrequency signal along. ET automatically calcu-
lates the vessel diameter changes during the cardiac cy-
cle and displays as a function of time on a curve. The
changes in elasticity of the carotid artery in patients
with carotid atherosclerosis, including stiffness parame-
ter (β), pressure-strain elastic modulus (Ep), Arterial
compliance (Ac), Augmentation Index (AI), and Pulse
Wave Velocity β (PVWβ), were calculated automatical-
ly. e-DMS then analyzed the stored curves and calculat-
ed elasticity coefficients automatically.
On the day of checked, the patients were required fast-
ing for at least 12 h. Sample venous blood was extract-
ed to assay biochemical index. Total cholesterol (TC),
Triglyceride (TG), High-density lipoprotein cholesterol
(HDL-C), Low-density lipoprotein cholesterol (LDL-
C), Aspertate Aminotransferase (AST), Alanine Amino-
transferase (ALT), Total Bilirubin (TBIL), Urea Nitro-
gen (BUN), Creatinine (Cr), Fasting Blood-Glucose
(GLU), Creatine phosphokinase (CPK) were detected
by a Beckman Synchron DX 800 automatic biochemi-
cal analyzer (Beckman Couler Inc., Brea, CA, USA).
Statistical analyses
All of the experimental data were expressed as the
means ± standard ( xˉ ± s). Differences in characteristics
between groups were compared by analysis of variance
(quantitative variables) or χ2 test. Statistical compari-
sons of all parameters between before and after treat-
ment were analyzed with a paired t-test. The SAS statis-
tical software, Version 9.0 (SAS Institute Inc., Cary,
NC, USA), was used for the analyses. Statistical signifi-
cant level was P < 0.05.
RESULTS
Participant flow
In intervention group, 4 patients withdrew from the
study due to deviation of trial schedule, 10 due to the
bad compliance, and the other 7 withdrew for changes
in telephones and other unknown reasons. While there
were 17 dropouts during the course of the study in the
control group because of above reasons respectively.
The flow diagram of this randomized trial is shown in
Figure 1.
Analyzed (n = 56)
Assessed for eligibility (n = 156)
Randomized
83 were assigned to intervention group 73 were assigned control group
4 patients withdrew from the study
due to deviation of trial schedule, 10
due to the bad compliance, and the
other 7 withdrew for changes in tele-
phones and other unknown reasons
3 patients withdrew from the study
due to deviation of trial schedule, 8
due to the bad compliance, and the
other 6 withdrew for changes in tele-
phones and other unknown reasons
Analyzed (n = 62)
Figure 1 Trial flow chart
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Baseline characteristics of the patients
The baseline characteristics, including gender, age,
body height, body mass index (BMI), courses, Systolic
Blood Pressure (SBP), Diastolic Blood Pressure (DBP),
TC, TG, HDL-C, LDL-C, BUN, Cr, GLU and CPK
of the patients in the two groups were matched. Base-
line characteristics of the study population are shown
in Table 1. The two groups did not differ greatly.
Comparison of the levels of baPWV and ABI
After 24 weeks of treatment, the level of baPWV was
decreased in both groups (P < 0.01 or P < 0.05), how-
ever, no significant difference of ABI was seen in both
groups. While there were no significant differences in
the parameters above mentioned between the two
groups (Table 2).
Comparison of results of Echo Tracking (ET)
After 24 weeks, results show that the parameters of the
carotid artery elasticity (β, Ep, AI and PWVβ) were
markedly decreased (P < 0.01), but Ac was improved
significantly in intervention group (P < 0.01). The ca-
rotid artery elasticity parameters including Ep, AI and
PWVβ were markedly decreased (P < 0.01), Ac was im-
proved significantly in intervention group (P < 0.01),
but the parameters of β had no changed in the control
group after 24 week treatment (P > 0.05). While there
were no significant differences in patients between the
two group (Table 3, Figure 2).
DISCUSSION
Atherosclerosis is a chronic and system disease that af-
fects the arterial structure or function, involves a com-
bination of fatty degeneration and of vessel stiffening
of the arterial wall. Atherosclerosis is mainly manifest-
ed as degeneration of the intima-media layer of the ar-
terial wall and increased collagen accumulation, result-
ing in age-related breakage of the elastic layers.14 Carot-
id IMT has been regarded as a valid surrogate marker
of atherosclerosis and is associated with cardiovascular
events. Arterial stiffness is significantly correlated with
cardiovascular disease (CVD) mortality. Increased arte-
rial stiffness and decreased arterial compliance are inde-
pendent risk predictors of cardiovascular disease.15
Arterial stiffness has been known to play a substantial
role in the development of cardiovascular disease
through the process of atherosclerosis, and it can be
measured non-invasively with PWV and ABI in
adults16. PWV not only reflects risks of adverse cardio-
vascular events but also predicts their prognosis.17 ABI
is simple and noninvasive screening tool for PAD. Ac-
cording to diagnostic criteria, and is reportedly associat-
ed with presence of coronary heart disease and their
progressions18. In additional it serves as a risk factor for
complications of coronary heart diseases, with greater
than 1.4 ABI being known to be related to the in-
creased mortality rate.
Shen DZ et al. / Clinical Study
Group
n
Gender (M/F)
Age (year)
body height (cm)
Weight (kg)
Body mass index
(kg/M2)
Courses (weeks)
SBP（mm Hg）
DBP（mm Hg）
TC (mmol/L)
TG (mmol/L)
HDL-C (mmol/L)
LDL-C (mmol/L)
BUN (mmol/L)
Cr (mmol/L)
BUA (mmol/L)
GLU (mmol/L)
CPK (mmol/L)
Intervention group
83
31/52
57.7±4.4
164.9±6.7
66.1±10.1
24.2±2.8
24
128.3±15.6
77.9±10.7
5.3±0.8
1.6±0.9
1.2±0.3
3.1±0.7
4.5±1.0
60.2±15.1
319.4±74.7
5.8±1.5
105.2±55.0
Control group
73
25/48
57.9±4.6
162.8±7.5
64.4±9.9
24.2±3.1
24
129.9±20.1
76.0±10.7
5.4±1.1
1.7±0.9
1.3±0.4
3.4±1.0
4.7±3.4
61.2±14.2
311.2±71.2
5.6±0.6
127.2±38.3
Table 1 Baseline characteristics of the patients( xˉ ± s)
Notes: intervention group was given Shoushen granule 6.2 g
once daily; control group was given Pravastatin 10 mg once dai-
ly. All treatments lasted 24 weeks. SBP: systolic blood pressure;
DBP: diastolic blood pressure; TC: total cholesterol; TG: triglyc-
eride; HDL-C: high-density lipoprotein cholesterol; LDL- C:
low-density lipoprotein cholesterol; BUN: urea nitrogen; Cr: cre-
atinine; BUA: blood uric acid; GLU: fasting blood-glucose;
CPK: creatine phosphokinase.
Group
Intervention
Control
Time
Pre-treatment
Post-24w-treatment
Pre-treatment
Post-24w-treatment
Case
83
62
73
56
baPWV（cm/s）
1545.86±233.77
1456.77±258.34a
1534.08±260.02
1487.42±230.98b
ABI
1.13±0.07
1.12±0.09
1.14±0.06
1.14±0.08
Table 2 Comparison of the levels of baPWV and ABI ( xˉ ± s)
Notes: intervention group was given Shoushen granule 6.2 g once daily; control group was given Pravastatin 10 mg once daily. All treat-
ments lasted 24 weeks. baPWV: brachial-ankle pulse wave velocity; ABI: ankle-brachial pressure index. Comparision between before and
after 24 week treatment in intervention group or control group, aP < 0.01, bP < 0.05.
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Clinically, it is mainly manifested that ET can detect
arterial elasticity changes with high sensitivity for as-
sessment of pathologic changes of the vascular wall in
patients at high risk of atherosclerosis. The basic princi-
ples of ET technology include first determining the
echo radiofrequency signals of the vessel wall, which
contain both the amplitude and the original phase in-
formation, and then automatically tracking method.
ET uses the zero-crossing technique to detect and fol-
low the phase shift of the ultrasound radiofrequency
signal generated by vessel wall motion during the cardi-
ac cycle. The phase shift is then converted to distance
in real-time and displayed as a time-motion curve,
which is stored by e-DMS for calculates a set of param-
eters of arterial wall elasticity automatically.19 Harden-
ing parameter β and Ep are the common indices for
evaluating arterial stiffness. β is the natural logarithm
of the systolic and diastolic pressure DBP ratio and is
therefore less affected by blood pressure.20 Ep, correlat-
ed with the elastic modulus, is a determinant of vessel
wall stress. An increase in Ep suggests arterial stiffness,
but Ep is vulnerable to the effects of pulse pressure.
PWVβ and AI were assessed for vessel wall stiffening
in this set of coefficient. The advantages of this technol-
ogy include reproducibility, noninvasiveness, and con-
venience of the original real-time data acquisition,
thereby providing an accurate and fast detection meth-
od for clinically assessing arterial stiffness.
Atherosclerosis, a chronic degenerative disease mainly
attacks the aged population, aging and other cardiovas-
cular disease risk factors also contribute to atherosclero-
sis. Regarding the treatment of carotid atherosclerosis,
using statins for primary prevention is recommended
by international guidelines. Statins can treat carotid
atherosclerosis by regulating blood lipid metabolism
and anti-inflammatory and thus stabilize atherosclero-
sis plaque.21 Statins also can improve arterial stiffness in
CAD patients significantly.22 However, it had been in-
creasing attached that the side-effects of statins such as
abnormal liver function and muscle problem including
Rhabdomyolysis. 23
Instead, "holism concept" advocated by TCM to treat
Group
Intervention
Control
Case
83
62
73
56
Time
Pre-treatment
Post-24w-
treatment
Pre-treatment
Post-24w-
treatment
IMT
(mm)
0.92±0.11
0.75±0.09a
0.90±0.12
0.75±0.11a
β
11.13±3.74
7.93±4.85a
11.16±3.79
10.38±4.32
Ep
(kPa)
143.62±53.50
118.51±81.82a
137.83±53.83
101.98±64.39a
Ac
(mm2/kPa)
0.50±0.35
0.67±0.29a
0.58±0.36
0.75±0.25a
AI
18.78±13.23
7.46±7.58a
14.55±8.66
8.39±8.08a
PWVβ
(m/s)
7.17±1.81
5.51±3.46a
7.27±1.51
5.27±3.02a
Table 3 Comparison of the levels of IMT and ET ( xˉ ± s)
Notes: intervention group was given Shoushen granule 6.2 g once daily, control group was given Pravastatin 10 mg once daily. All treat-
ments lasted 24 weeks. IMT: intima-media thickness; β: stiffness parameter; Ep: pressure-strain elastic modulus; AC: arterial complianc;
AI: Augmentation Index; PWVβ: pulse wave velocity β. Comparision between before and after 24 week treatment in the same group, aP <
0.01.
Figure 2 Results of echo-tracking technique examination
A-C: the change and movement curve shape of the IMT and the parameters of artery elasticity in patients with carotid atheroscle-
rosis before treatment; B-F: the change and movement curve shape of the IMT and the parameters of artery elasticity in patients
with carotid atherosclerosis after treatment. A and D: continuous measurement of carotid artery intima; B and E: ET elasticity test;
C and F: analysis of signal wave. IMT: intima-media thickness.
A B C
D E F
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atherosclerosis had been heeded more and more. Using
Chinese herbal therapy has its unique advantage in an-
ti-atherosclerosis with less side-effect, although the fi-
nal effect of reinforcing kidney herbs on stabilizing
plaque was slightly less than that of simvastatin. Meth-
od of reinforcing kidney is an effective TCM therapeu-
tical principle of anti-atherosclerosis. Reinforcing kid-
ney has been widely used for preventing atherosclerosis
by multiple ways. Our previous work have also found
that Compound Chinese medicine for reinforcing kid-
ney could not only effects on restraining atherosclerosis
obviously, but also show significant effects on amelio-
rating the symptoms and functions of senility.24,25
Therefore, Chinese herbal medicines, especially com-
pound recipes, warrant further investigation and might
be a complementary or alternative therapy to statins in
stabilizing vulnerable plaque through a synergistic and
multi-targeted effect.
Based on the TCM and our previous research results,
we regarded that Shoushen granule, a compound reci-
pe of reinforcing kidney, is suitable for carotic athero-
sclerosis. Shoushen granule was formed by Heshouwu
(Radix Polygoni Multiflori), Gouqizi (Fructus Lycii),
Shanzha (Fructus Crataegus Pinnatifidae) and Sanqi
(Radix Notoginseng). Combination of various drugs,
there were efficiency of nourishing the kidney and
strengthening the essence, and promoting blood circu-
lation to dispel blood stasis. Previous study have been
proved that Shoushen granule is an effective recipe for
preventing atherosclerosis,11 and it can interfere carotid
artherosclerosis pathological changes by adjusting disor-
der of lipid metabolism and reducing the expression
levels of C Reactive Protein and Interleukin 6.12
In the present study, the intervention group, had lower
IMT, baPWV, β, Ep, PWV β, AI and higher AC after
24 week treatment. In the control group, partly elastici-
ty coefficients did also change significantly, while there
were no significant differences to aimed at mentioned
parameters between the two groups simultaneously.
Those demonstrated that Shoushen granule and pravas-
tatin had a powerful effect on arterial function and
morphologic changes, and also indicated that the effect
of Shoushen granule was at least not inferior to that of
statins for ameliorating arterial elasticity. In addition,
ABI had no significant changes after treatment in the
two groups. ABI index of all subjects were limited
0.9-1.3, indicated those patients with PAD were ex-
cluded. So, result of ABI was reasonable.
In summary, ET technology and automated arterioscle-
rosis detector could detect arterial elasticity changes
with high sensitivity. The present study suggested that
Shoushen granule in improved arterial elasticity for pa-
tients with carotid atherosclerosis. The mechanism of
Shoushen granule might be related to the regulation of
vascular elasticity. Shoushen granule also could de-
crease carotid artery IMT for changing arterial morpho-
logic.
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